PubMed Health⌕ Search

PubMed · 11470968

Autonomic dysfunction in movement disorders.

Abstract

Dysfunction of the autonomic nervous system is an under-recognised but important aspect of the aetiological and clinical manifestation of primary degenerative dysautonomias such as multiple system atrophy (MSA) and Parkinson's disease (PD). Although the clinical presentation of dysautonomia in these two disorders may overlap, yet pathological and in vivo imaging studies suggest considerable differences. Functional imaging studies suggest that selective cardiac sympathetic denervation may occur early in PD but not in other parkinsonian syndromes. The clinical implication of this apparently disease specific peripheral dysautonomia is unknown and would be the subject of much interest in future years. Dysautonomia in degenerative disorders also affect respiration, genitourinary function and sleep. Sleep related disorders such as rapid eye movement behaviour disorder and urinary voiding dysfunction appear to precede the development of PD related symptoms while patients with sporadic ataxia have been shown to progress to develop MSA. Dysautonomia has also been recognised in other movement disorders, examples being the combination of dystonia and complex regional pain syndrome with elevated HLA-DR13 and late onset Huntington's disease presenting with dominant parkinsonism and minimal chorea. These studies have helped progress in various diagnostic and management parameters in relation to autonomic dysfunction and movement disorders.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K R Chaudhuri. 2001. Autonomic dysfunction in movement disorders.. https://doi.org/10.1097/00019052-200108000-00012

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy.

Norepinephrine (NE) is the major neurotransmitter of the sympathetic division of the autonomic nervous system (ANS). Recent findings of an association between human NE deficiency and variants at the dopamine beta-hydroxylase (DBH) gene [Kim et al., 2002] prompted us to investigate these markers in patients with autonomic disorders; 38 with orthostatic intolerance (OI), 26 with pure autonomic failure (PAF), and 39 with multiple system atrophy (MSA). Eighty-eight normal controls were included in this study. In contrast to NE deficiency, allele frequency and genotype distribution of the genetic variants showed no differences between autonomic disease patients and controls. In addition, no DBH mutation was found that distinguished autonomic disease patients from controls, suggesting that genetic variants of the DBH gene are not associated with the autonomic diseases OI, PAF, and MSA.

Autonomic Nervous System Diseases↗

[Diagnostic criteria and differential diagnosis of Parkinson disease].

The clinical diagnosis of Parkinson's disease is based on the identification of some combination of the clinical motor signs of bradykinesia, rigidity, tremor and postural instability. Three levels of diagnostic confidence are differentiated: possible, probable, and definite. The diagnosis of possible and probable Parkinson's disease based on clinical criteria alone, while definite diagnosis requires neuropathologic confirmation. To differentiate Parkinson's disease (idiopathic Parkinsonian syndrome) and other Parkinsonian syndromes is of increasing importance considering the therapy and life expectancy of the patients. Recently the functional imaging technics have been more and more helpful in the early differential diagnosis of Parkinson's disease.

Autonomic Nervous System Diseases↗